SEC Form 4 · accession 0001209191-19-005622
ARATANA THERAPEUTICS, INC. · PETX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Craig A Tooman
Officer — President, CEO and CFO · Director
Period of report
Jan 24, 2019
Accepted (ET)
Jan 28, 2019 · 5:50 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001509190
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 24, 2019 | A | 211,267 | $0.00 | A | 325,991 | D | |
| Common StockF1 | Jan 24, 2019 | F | 18,490 | $4.22 | D | 307,501 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $4.22 | Jan 24, 2019 | A | 222,222 | A | — | Jan 23, 2029 | Common Stock | 222,222 | 222,222 | D |
Explanation of responses
- F1Represents shares withheld on January 24, 2019 to satisfy tax withholding obligations in connection with the vesting of restricted stock.
- F2Vests as to 25% of the total number of shares (rounded down to the nearest whole share) on January 29, 2020 and as to an additional 1/48th of the total number of shares (rounded down to the nearest whole share) on the same day of each of the 36 successive calendar months thereafter, such that the stock option shall be vested as to all shares on January 29, 2023, subject to continued service with the Issuer through the applicable vesting dates.